Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Clin Cancer Res. 2017 Mar 24;23(15):4493–4500. doi: 10.1158/1078-0432.CCR-16-2845

Table 3.

Multivariate analysis testing the probability of pCR as a function of intrinsic breast subtype and RPS

Variable Odds Ratio (95%CI) P-value
Array-based subtypes
 Luminal A 1 (reference)
 Basal 9.30 (4.02–25.5) <0.0001
 HER2-enriched 7.20 (2.50–22.7) 0.0002
 Luminal B (HER2 negative) 3.40 (1.21–10.4) 0.020
 Luminal B (HER2 positive) 3.79 (0.47–21.9) 0.19
RPS value (per one unit decrease) 1.48 (1.04–2.10) 0.027

Odds ratio of pCR determined using multivariate logistic regression analysis of the indicated covariates. Odds ratios for intrinsic subtypes were calculated relative to Luminal A tumors. Chi-square P-value determined using likelihood ratio test. CI=confidence interval.